tiprankstipranks
Biorem Inc (TSE:BRM)
TSXV:BRM
Canadian Market
Holding TSE:BRM?
Track your performance easily

Biorem Inc (BRM) Technical Analysis

8 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Biorem Inc’s (BRM) Moving Averages Convergence Divergence (MACD) indicator is 0.10, suggesting Biorem Inc is a Buy.
Biorem Inc’s (BRM) 20-Day exponential moving average is 2.88, while Biorem Inc’s (BRM) share price is C$3, making it a Buy.
Biorem Inc’s (BRM) 50-Day exponential moving average is 2.69, while Biorem Inc’s (BRM) share price is C$3, making it a Buy.

Biorem Inc (BRM) Pivot Points

Nov 30, 2024, 04:24 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.89
2.93
3.00
3.04
3.12
3.16
3.23
Fibonacci
2.93
2.97
3.00
3.04
3.09
3.11
3.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biorem Inc (BRM) Moving Averages

Nov 30, 2024, 04:24 AM
Period
Simple
Exponential
MA5
2.96Buy
2.98Buy
MA10
2.92Buy
2.95Buy
MA20
2.90Buy
2.88Buy
MA50
2.65Buy
2.69Buy
MA100
2.42Buy
2.47Buy
MA200
2.10Buy
2.10Buy
Biorem Inc’s (BRM) 10-Day exponential moving average is 2.95, while Biorem Inc’s (BRM) share price is C$3, making it a Buy.
Biorem Inc’s (BRM) 100-Day exponential moving average is 2.47, while Biorem Inc’s (BRM) share price is C$3, making it a Buy.
Biorem Inc’s (BRM) stock price is C$3 and Biorem Inc’s (BRM) 50-day simple moving average is 2.65, creating a Buy signal.
Biorem Inc’s (BRM) stock price is C$3 and Biorem Inc’s (BRM) 100-day simple moving average is 2.42, creating a Buy signal.
Biorem Inc’s (BRM) stock price is C$3 and Biorem Inc’s (BRM) 200-day simple moving average is 2.10, creating a Buy signal.

Biorem Inc (BRM) Technical Indicators

Nov 30, 2024, 04:24 AM
Name
Value
Implied Action
RSI (14)
56.46
Neutral
STOCH (9,6)
86.14
Sell
STOCHRSI (14)
46.86
Neutral
MACD (12,26)
0.10
Buy
ADX (14)
30.37
Neutral
Williams %R
-59.42
Buy
CCI (14)
54.78
Neutral
ATR (14)
0.15
-
Ultimate Oscillator
49.23
Neutral
ROC
-4.18
Sell
Biorem Inc’s (BRM) Relative Strength Index (RSI) is 56.46, creating a Neutral signal.
Biorem Inc’s (BRM) Trend Strength Indicator (ADX) is 30.37, creating a Neutral signal.
Biorem Inc’s (BRM) Commodity Channel Index (CCI) is 54.78, creating a Neutral signal.
Biorem Inc’s (BRM) Price Rate of Change (ROC) is -4.18, creating a Sell signal.

FAQ

Is BRM a Buy, Hold, or Sell?
Based on BRM’s technical indicators, BRM is a Strong Buy.
    What is BRM’s RSI (14)?
    BRM’s RSI (14) is 56.46, which suggests BRM is a Neutral.
      What is BRM’s MACD?
      BRM’s MACD is 0.10, which suggests BRM is a Buy.
        What is BRM’s 5-day moving average?
        BRM’s 5-day moving average is 2.96, which suggests BRM is a Buy.
          What is BRM’s 20-day moving average?
          BRM 20-day moving average is 2.90, which suggests BRM is a Buy.
            What is BRM’s 50-day moving average?
            BRM’s 50-day moving average is 2.65, which suggests BRM is a Buy.
              What is BRM’s 200-day moving average?
              BRM’s 200-day moving average is 2.10, which suggests BRM is a Buy.
                What is BRM’s Williams % R (14)?
                BRM’s Williams % R (14) is -59.42, which suggests BRM is a Buy.
                  What is BRM’s CCI (14)?
                  BRM’s CCI (14) is 54.78, which suggests BRM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis